93
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The added value of lung perfusion scintigraphy semiquantitative measures in post-COVID patients with persistent dyspnea without pulmonary embolism

ORCID Icon, , , , , , , , , , , , & ORCID Icon show all
Pages 1243-1249 | Received 03 Jul 2023, Accepted 04 Oct 2023, Published online: 02 Nov 2023

References

  • Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019
  • Chen C, Haupert SR, Zimmermann L, et al. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593–1607. doi: 10.1093/infdis/jiac136
  • Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427
  • Fabbri L, Moss S, Khan FA, et al. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax. 2022;78(2):191–201. doi: 10.1136/thoraxjnl-2021-218275
  • Solomon JJ, Heyman B, Ko JP, et al. CT of post-Acute lung complications of COVID-19. Radiology. 2021;301(2):e383–e395. doi: 10.1148/radiol.2021211396
  • Vijayakumar B, Tonkin J, Devaraj A, et al. CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge. Radiology. 2022;303(2):444–454. doi: 10.1148/radiol.2021211746
  • Noel-Savina E, Viatgé T, Faviez G, et al. Severe SARS-CoV-2 pneumonia: clinical, functional and imaging outcomes at 4 months. Respir Med Res. 2021;80:100822. doi: 10.1016/j.resmer.2021.100822
  • Bisaccia G, Ricci F, Recce V, et al. Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know? J Cardiovasc Dev Dis. 2021;8(11):156. doi: 10.3390/jcdd8110156
  • Taga A, Lauria G. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era. J Peripher Nerv Syst. 2022;27(1):4–30. doi: 10.1111/jns.12482
  • Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021;9(3):e14726. doi: 10.14814/phy2.14726
  • Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N Engl J Med. 2020;383(2):120–128. doi: 10.1056/NEJMoa2015432
  • Carrier M, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost. 2010;8:1716–1722. doi: 10.1111/j.1538-7836.2010.03938.x
  • Dhawan RT, Gopalan D, Howard L, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med. 2021;9:107–116. doi: 10.1016/S2213-2600(20)30407-0
  • Sajal D, Mudalsha R, Tinu L, et al. Lung perfusion scintigraphy early after COVID-19: a single-center retrospective study. J Nucl Med Technol. 2021;49(4):320–323. doi: 10.2967/jnmt.121.262440
  • Bajc M, Schümichen C, Grüning T, et al. EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond. Eur J Nucl Med Mol Imaging. 2019;46(12):2429–2451. doi: 10.1007/s00259-019-04450-0
  • Smadja DM, Mentzer SJ, Fontenay M, et al. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021;24(4):755–788. doi: 10.1007/s10456-021-09805-6
  • Ravaglia C, Doglioni C, Chilosi M, et al. Clinical, radiological, and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J. 2022;60(4):2102411. doi: 10.1183/13993003.02411-2021
  • Buonsenso D, Di Giuda D, Sigfrid L, et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc Health. 2021;5(9):677–680. doi: 10.1016/S2352-4642(21)00196-6
  • Pizzuto DA, Buonsenso D, Morello R, et al. Lung perfusion assessment in children with long-COVID: a pilot study. Pediatr Pulmonol. 2023;58:2059–2067. doi: 10.1002/ppul.26432
  • Heiss R, Tan L, Schmidt S, et al. Pulmonary dysfunction after pediatric COVID-19. Radiology. 2023;306(3):e221250. doi: 10.1148/radiol.221250
  • Grist JT, Collier GJ, Walters H, et al. Lung abnormalities detected with hyperpolarized 129 xe MRI in patients with long COVID. Radiology. 2022;305(3):709–717. doi: 10.1148/radiol.220069
  • Grist JT, Chen M, Collier GJ, et al. Hyperpolarized 129Xe MRI abnormalities in dyspneic patients 3 months after COVID-19 pneumonia: preliminary Results. Radiology. 2021;301(1):e353–e360. doi: 10.1148/radiol.2021210033
  • Monaco L, Crivellaro C, Cressoni M, et al. The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism. Eur J Nucl Med Mol Imaging. 2021;48(10):3020–3021. doi: 10.1007/s00259-021-05377-1
  • Yu B, Li X, Chen J, et al. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J Thromb Thrombolysis. 2020;50(3):548–557. doi: 10.1007/s11239-020-02171-y
  • Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18:1421–1424. doi: 10.1111/jth.14830
  • Léonard-Lorant I, Delabranche X, Séverac F, et al. Acute pulmonary embolism in patients with COVID-19 at CT angiography and relationship to d-dimer levels. Radiology. 2020;296(3):e189–e191. doi: 10.1148/radiol.2020201561
  • Evans RA, Leavy OC, Richardson M, et al. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761–775. doi: 10.1016/S2213-2600(22)00127-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.